Aclarion (ACON) Short-Term Debt issuances (2021 - 2024)
Aclarion posted quarterly Short-Term Debt issuances of $304500.0 for Q2 2024, down 78.99% on a QoQ basis from $1.4 million in Q1 2024.
Aclarion (ACON) has 4 years of Short-Term Debt issuances data on file, last reported at $304500.0 in Q2 2024.
- For the quarter ending Q2 2024, Short-Term Debt issuances changed N/A year-over-year to $304500.0; the trailing twelve-month figure through Mar 2025 stood at $304500.0 (down 89.54% YoY), and the FY2024 full-year result was $1.8 million, up 19.9% from the prior year.
- Short-Term Debt issuances for Q2 2024 stood at $304500.0, down from $1.4 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $2.0 million in Q3 2022 and bottomed at -$1.9 million in Q4 2021.
- The 4-year median for Short-Term Debt issuances is $1.4 million (2024), against an average of $668396.2.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Aclarion | 7.18 Mn | -11.57 Mn | 3,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 304,500.00 |
| Jun 30, 2024 | 304,500.00 |
| Mar 31, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Dec 31, 2021 | -1.88 Mn |
| Dec 31, 2021 | -1.88 Mn |